Trevena Inc (NAS:TRVN)
$ 6.7 -0.79 (-10.55%) Market Cap: 5.71 Mil Enterprise Value: 26.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 23/100

Q3 2023 Trevena Inc Earnings Call Transcript

Nov 14, 2023 / 01:00PM GMT
Release Date Price: $14.81 (-1.12%)
Operator

Greetings and welcome to Trevena Inc, third quarter 2023 Earnings Call. At this time, all participants are in a listen only mode. (Operator Instructions) As a reminder, this conference is being recorded and it is now my pleasure to introduce the host, Barry Shin Chief Financial Officer. Thank you, Mr. Barry Shin, you may begin.

Barry Shin
Trevena Inc - CFO, SVP

Good morning and welcome, everyone. With me today are Carrie Bourdow, our President and CEO, Patricia Drake, our Chief Commercial Officer, and Mark Demitrack our Chief Medical Officer. We're also joined by Dr. Daniel Clauw, a key opinion leader and paid scientific consultant with Trevena to provide his views on our recent TRV over five proof-of-concept data.

Dr. Clark is a rheumatologist, a leading expert of CNS mechanisms in pain and Professor of Anesthesiology medicine and Psychiatry at the University of Michigan. We'll also be making forward-looking statements under federal securities law. These statements are subject to risks and uncertainties related to our business, including those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot